First Trust Advisors
ABUS icon

First Trust Advisors’s Arbutus Biopharma ABUS Stock Holding History

First Trust Advisors’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.33M Buy
+696,258
New +$3.36M ﹤0.01% 1808

Other funds holding ABUS

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

First Trust Advisors's ABUS Position: Q3 2026 in Review

First Trust Advisors opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 696,258 shares worth $3.33M. The stake represents ﹤0.01% of the portfolio and ranks #1808 among its holdings.

107 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • First Trust Advisors held 696,258 shares of Arbutus Biopharma worth $3.33M as of Q3 2026.
  • Arbutus Biopharma was a new First Trust Advisors position in Q3 2026.
  • Arbutus Biopharma made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #1808 holding.
  • 107 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.